Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,256 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,466
Recruiting: 821
Ph III recruiting: 96
Growth YoY: +7.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 5,701–5,750 of 6,256 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01888159	Salpingectomy vs Tubal Sterilisation in Low Risk for Ovarian Cancer Women and Its Effect on Ovarian Reserve	unknown	N/A	100	Karlstad Central HospitalOTHER	1	Jun 27, 2013	clinicaltrials
NCT00002489	Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors	completed	Phase 2	—	Memorial Sloan Kettering Cancer CenterOTHER	1	Jun 26, 2013	clinicaltrials